Modified Citrus Pectin: What It Does

Modified citrus pectin is an unusual supplement: a citrus fibre deliberately broken into smaller pieces so a fraction can be absorbed rather than passing through the gut.

Wider context sits in our longevity supplements guide and the anti aging supplements range. For this category specifically, see the pectin supplements collection, our Ultra Purity Modified Citrus Pectin Powder and the clinically studied PectaSol-C range.

This guide explains what MCP does, what the human evidence does and does not support, how it is dosed, who should avoid it, and what to look for when buying in the UK. Where the evidence is weak, we say so plainly.

What is modified citrus pectin?

Modified citrus pectin is a soluble dietary fibre derived from the peel and pith of citrus fruit — usually lemons, limes, oranges or grapefruit — chemically or enzymatically processed to reduce its molecular size [9].

Citrus peel is one of the richest natural sources of pectin. In its natural state that pectin is a very large molecule and behaves purely as a bulk fibre.

Pectin vs modified citrus pectin: the key difference

In plain terms: standard pectin is too big to leave the gut. Modified citrus pectin is small enough that some of it does. That is the entire premise of the category, and it is why a jam-setting pectin sachet is not a substitute for a properly specified MCP powder.

How it is made

Manufacturers use controlled pH adjustment and heat, sometimes with enzymatic treatment, to depolymerise native citrus pectin. This shortens the chains of galacturonic acid forming the pectin backbone and strips away most methyl ester groups [9].

The result is a fine, off-white to pale beige powder that dissolves readily in water. The best-characterised commercial material used in published research had a weight-average molar mass of about 15,400 daltons and a degree of esterification of 3.8% [9].

What "low molecular weight" means on a UK label

This is where UK shoppers get caught out. "Citrus pectin" and "modified citrus pectin" appear on labels almost interchangeably, but the specification underneath varies enormously.

A genuine MCP product should disclose, or supply on request:

• Average molecular weight (roughly 10–30 kDa)
• Degree of esterification (typically under 10%)
• Galacturonic acid content (commonly 80% or above)
• A batch-specific certificate of analysis

If a product lists none of these, you are likely buying a general-purpose citrus fibre rather than a low molecular weight modified pectin. See reading a supplement certificate of analysis and third-party tested supplements.

What it does in the body

MCP has three plausible and partially independent mechanisms. Only one is unique to the modified form.

Galectin-3: the protein at the centre of the science

Galectin-3 is a beta-galactoside-binding lectin — a protein recognising and attaching to specific sugar structures on cell surfaces and in the extracellular matrix. Secreted largely by macrophages, it is involved in cell adhesion, inflammatory signalling, tissue repair and fibrosis [9,11].

MCP contains galactan side chains within its rhamnogalacturonan-I regions. These fit the carbohydrate recognition domain of galectin-3, allowing MCP to act as a competitive ligand and occupy the site galectin-3 would otherwise use [9].

Why galectin-3 matters for fibrosis

When galectin-3 activity is persistently elevated, it drives fibroblast proliferation and collagen deposition — the process turning functional tissue into scar tissue [11]. A study at the UCL Institute of Child Health found MCP reduced galectin-3 expression and disease severity in an experimental model of acute kidney injury [10]. Reviews describe reductions in fibrosis in kidney, liver, cardiac and adipose tissue in animal models [9].

Fibrosis and chronic low-grade inflammation are recognised features of biological ageing, which is why MCP appears in longevity discussions — see the hallmarks of ageing.

Galectin-3 as a clinical biomarker

Galectin-3 is not a fringe concept. It has been cleared in the United States as a prognostic blood test in heart failure, and meta-analyses have examined its association with cardiovascular mortality, all-cause mortality and incident heart failure [11,12]. Its independent prognostic value relative to established markers such as NT-proBNP remains debated [11].

Binding and elimination of certain heavy metals

The second mechanism relates to the rhamnogalacturonan-II fraction of pectin, which chelates metal ions. Because MCP is partly absorbed, the proposal is that it can bind circulating toxic metals and increase urinary elimination — as opposed to standard fibre, which can only bind metals inside the gut lumen [6,9]. Human data is limited to small pilot studies, discussed below.

Soluble fibre effects in the gut

The third mechanism is the least glamorous and best established. MCP is still a soluble fibre: pectin increases viscosity and stool volume, binds cholesterol and bile acids, slows glucose absorption, and is fermented into short-chain fatty acids [15].

Pectin consumption has been shown to reduce LDL cholesterol modestly, around 3–7% depending on source and type [13]. Note these fibre effects are strongest with intact, higher molecular weight pectin — heavily depolymerised MCP is a weaker gelling fibre, so it is a poor choice if bulk fibre is your actual goal.

If gut health is your primary interest, a butyrate supplement or an Akkermansia muciniphila product is a more direct route — see also the gut health range.

The evidence: what human studies actually show

This section matters most, and needs reading carefully. MCP has an interesting mechanism and a genuinely thin human evidence base.

Prostate cancer and PSA doubling time

The most-cited human research involves men with biochemically relapsed prostate cancer — PSA rising after surgery or radiotherapy, with no detectable metastases.

The 2003 pilot

A phase II pilot gave 10 men 14.4 g of MCP per day (4.8 g three times daily) for 12 months. PSA doubling time increased significantly in 7 of the 10 men [3].

The 2021 prospective phase II study

A larger multicentre study across Israeli centres recruited between 2013 and 2019 enrolled 60 men; one withdrew after a month, leaving 59. Using the same 4.8 g three times daily protocol for six months [4]:

• 78% (n = 46) responded — decreased or stable PSA in 58% (n = 34), or improved PSA doubling time in 75% (n = 44), all with negative scans.
• Median PSA doubling time improved significantly (p = 0.003).
• Disease progression occurred in 22% (n = 13): PSA progression in 17% (n = 10), and both PSA and radiologic progression in 5% (n = 3).
• No patients developed grade 3 or 4 toxicity.

The 2023 long-term phase

Of the 46 patients entering a further 12 months, 7 withdrew consent and 39 continued. After 18 months in total, 85% (n = 33) had a durable response, 62% (n = 24) showed decreased or stable PSA, and 90% (n = 35) showed PSA doubling time improvement, all with negative scans. No grade 3 or 4 toxicity [5].

What this does and does not mean. These are single-arm studies without placebo control. PSA doubling time is a surrogate marker, not survival. Cancer Research UK classes MCP as an alternative therapy and states there is no scientific evidence it can cure or prevent cancer [1]. Memorial Sloan Kettering similarly describes the human data as limited and preliminary [2].

Heavy metal excretion studies

The best-known study is a 2006 pilot in Phytotherapy Research. Eight healthy adults took 15 g of MCP daily for five days, then 20 g on day six, with 24-hour urine collections on day one and day six [6].

A separate hospital-based pilot in China gave 15 g/day in divided doses to children aged 5–12 with elevated blood lead, reporting a fall in blood lead and a rise in 24-hour urinary lead excretion, with no adverse events [7].

The counter-argument deserves equal weight. A 2008 critical analysis in Alternative Medicine Review identified serious methodological problems with the 2006 study: no placebo or crossover arm, a tiny sample, uncontrolled dietary and environmental exposures during collection, no reported testing of the MCP itself for heavy metal content, and a headline lead figure that did not reach conventional significance [8]. These criticisms have not been resolved by any larger trial since.

The honest summary is that MCP's metal-binding effect is biologically plausible and supported by two small uncontrolled pilots. That is a long way from established.

Kidney, heart and fibrosis research

Currently preclinical. The UCL acute kidney injury model showed reduced galectin-3 expression and reduced disease severity [10]. Reviews summarise animal data showing reduced fibrosis in kidney, heart, liver and adipose tissue [9]. There are no published randomised controlled trials of MCP for fibrotic disease in humans. Treat anything about MCP "reversing fibrosis" as animal data until a human trial says otherwise.

Evidence strength at a glance

MCP sits in a similar evidential position to several other compounds we have assessed — worth understanding, not worth overselling. See longevity supplements that don't work for the framework we use.

Who funded and authored this research

Because we sell this product, we think you should know how the evidence base was produced.

Nearly all the human MCP research uses one branded material — PectaSol, made by EcoNugenics — and one researcher, Dr Isaac Eliaz, who is associated with that company, appears as an author across much of it: the 2006 heavy-metals pilot [6], the 2019 Nutrients review of MCP's effects [9], and the Keizman prostate trials [4,5]. This is disclosed in the papers themselves and is not hidden.

Dosage and timing

Doses used in research

Almost every meaningful human study has used the same target: approximately 15 g per day, split into three doses of about 5 g. The prostate studies used 4.8 g three times daily [3,4,5]. The heavy metal pilots used 15 g/day, briefly rising to 20 g [6,7]. This is a very high dose by supplement standards.

Practical UK dosing

Single-ingredient powders such as Welzo Ultra Purity Modified Citrus Pectin Powder and the clinically studied PectaSol-C range therefore dominate the category. Compare formats across the full pectin supplements collection.

When to take it

Standard practitioner guidance is to take MCP on an empty stomach, dissolved in water, at least 30–60 minutes before food and at least two hours away from medication and mineral supplements [1,2]. Two reasons: absorption of the low molecular weight fraction is thought to be better without competing food volume, and pectin can interfere with the absorption of some medicines and minerals taken at the same time.

See which supplements to take on an empty stomach, the supplement timing chart, and whether you can take supplements together.

How long before anything happens

MCP produces no acute, perceptible effects. There is no energy hit and no immediate subjective change. PSA doubling time changes were measured at six and twelve months [4,5]. Urinary metal excretion changes were measured within days but are not something you can feel [6].

Realistically, plan a minimum of three months and ideally use an objective measure agreed with your clinician. See how long supplements take to work.

Side effects, safety and interactions

Pectin has an unusually reassuring regulatory safety profile. The European Food Safety Authority re-evaluated pectin (E440i) and amidated pectin (E440ii) and concluded there was no safety concern at reported use levels, with no need to set a numerical acceptable daily intake [14].

That said, "safe as a food additive at gram-level intakes" is not the same as "consequence-free at 15 g/day".

Common side effects

• Bloating and abdominal distension
• Flatulence
• Loose stools or, less commonly, constipation
• Abdominal cramping
• Mild nausea

Cancer Research UK notes that in large quantities MCP may cause diarrhoea, stomach pains and wind [1]. A pilot study in patients with advanced solid tumours reported itching, indigestion and flatulence as the most common adverse events [1]. Most gastrointestinal effects are dose-related and settle when the dose is reduced or split further. No grade 3 or 4 toxicity occurred in the prostate trials [4,5].

Interactions and cautions

Anyone taking prescription medication — particularly anticoagulants, thyroid hormone, statins, antibiotics or immunosuppressants — should speak to a pharmacist or GP before adding a high-dose fibre supplement.

Buying modified citrus pectin in the UK

In Great Britain, MCP is sold as a food supplement, not a medicine. Food supplements are regulated as food and are not assessed for efficacy before sale, and cannot legally carry claims to prevent, treat or cure disease [16,17]. The burden of quality assessment falls on you.

What to check before you buy

Fillers are a particular issue in cheaper powders — see supplement fillers.

Powder versus capsules

Powder is the format used in every clinical study, is far cheaper per gram, and lets you titrate. Trade-offs: a mildly sour citrus taste, the need to mix properly, and the daily ritual of measuring.

Capsules are convenient and portable but deliver doses far below anything studied. They suit someone taking MCP as a general fibre rather than for a specific mechanistic reason.

What it costs

A 454 g tub provides roughly 90 servings at 5 g — about three months at 5 g/day, or about one month at the full research dose of 15 g/day. Running MCP at the research dose is therefore a materially expensive commitment relative to most longevity supplements. See longevity stack cost in the UK and why supplements are expensive.

Where MCP fits in a wider routine

MCP is a niche addition, not a foundation. For most people building a routine from scratch, the higher-evidence categories come first: creatine, omega-3, vitamin D, protein adequacy and NAD⁺ precursors. See how to build a longevity stack, the minimal supplement stack, how to start longevity supplements, the NMN benefits, side effects and dosage guide, the NMN supplements range and NMN Pro 1000.

How MCP compares to other supplements

Read more: urolithin A in the UK, buying spermidine in the UK, creatine for longevity, NAC supplements in the UK and autophagy explained.

Frequently asked questions

What does modified citrus pectin actually do?

It is a low molecular weight citrus fibre acting as a competitive binder of galectin-3, a protein involved in inflammation, cell adhesion and tissue fibrosis [9]. It also binds certain toxic metals and, like all pectin, functions as a soluble fibre [6,15]. The galectin-3 mechanism is well characterised in the laboratory, but human outcome data remains limited to small early-phase studies.

Is modified citrus pectin available in the UK?

Yes. MCP is sold legally in the UK as a food supplement in powder and capsule form. It is regulated as food rather than medicine, so it is not assessed for efficacy before sale and cannot legally be marketed as treating any disease [16,17].

What is the correct modified citrus pectin dosage?

Published human studies used approximately 15 g per day, split into three 5 g doses [3,4]. Many people start at 5 g once daily to assess tolerance. Capsule products typically deliver only 1.8–3 g per day, far below any studied dose. Follow the product label and speak to a clinician before using high doses long term.

What is the difference between citrus pectin and modified citrus pectin?

Standard citrus pectin is a large molecule of roughly 60–300 kDa that is not absorbed and acts purely as a gut fibre and gelling agent. Modified citrus pectin has been depolymerised to around 10–30 kDa with most methyl ester groups removed, allowing a portion to be absorbed and to interact with galectin-3 systemically [9]. They are not interchangeable.

Does modified citrus pectin remove heavy metals?

Two small uncontrolled pilots reported increased urinary excretion of arsenic, cadmium and lead at 15 g/day, without increased loss of calcium, magnesium, zinc, iron or selenium [6,7]. However, a published critical analysis identified significant methodological weaknesses including no placebo group and uncontrolled environmental exposures, and noted the headline lead figure did not reach conventional significance [8]. Regard the evidence as preliminary rather than established.

Can modified citrus pectin treat cancer?

No. Cancer Research UK states there is no scientific evidence that modified citrus pectin can cure or prevent cancer, and classes it as an alternative therapy [1]. Two single-arm phase II studies in men with biochemically relapsed prostate cancer reported improvements in PSA doubling time — a surrogate marker rather than a survival outcome — and the long-term study's own authors note its 90% figure reflects a cohort pre-selected for having already responded [4,5]. Anyone with a cancer diagnosis should discuss any supplement with their oncology team before starting.

What are the side effects of modified citrus pectin?

Most common are gastrointestinal: bloating, flatulence, abdominal cramping and loose stools, all dose-related [1]. Itching and indigestion have also been reported. People allergic to citrus fruit should avoid MCP entirely, and it should be separated from medication by at least two hours because pectin can interfere with drug absorption [2].

When should you take modified citrus pectin?

Usually on an empty stomach, dissolved in water, 30–60 minutes before food, and at least two hours away from any medication or mineral supplement [1,2]. Splitting the total daily amount into two or three doses improves both tolerability and consistency.

How long does modified citrus pectin take to work?

MCP produces no acute or perceptible effects. Changes in urinary metal excretion were measurable within days [6], while PSA doubling time changes were assessed at six and twelve months [4,5]. A realistic trial period is at least three months, ideally alongside an objective marker agreed with a clinician.

Is modified citrus pectin safe to take long term?

Pectin has a strong regulatory safety record — EFSA found no safety concern for pectin as a food additive and concluded no numerical acceptable daily intake was needed [14]. Human MCP studies lasting up to 18 months reported no grade 3 or 4 toxicity [5]. However, long-term supplement-dose safety data in healthy populations is limited, and anyone using MCP continuously should review it periodically with a healthcare professional.

Key takeaways

• MCP is citrus pectin broken down to roughly 10–30 kDa so a fraction can be absorbed rather than passing through the gut [9].
• Its defining mechanism is competitive binding of galectin-3, a protein implicated in inflammation, cell adhesion and tissue fibrosis [9,11].
• Galectin-3 is a recognised prognostic biomarker in heart failure, but no trial has shown that lowering it with a supplement changes outcomes [11,12].
• Human evidence consists of two single-arm phase II prostate studies and two small heavy-metal pilots — preliminary, uncontrolled, and one substantively criticised [3,4,5,6,7,8].
• Most of that literature involves one branded product and one commercially associated author. Independent replication does not yet exist [4,5,6,9].
• Cancer Research UK is explicit that MCP is not a cancer treatment and there is no evidence it cures or prevents cancer [1].
• Research doses are approximately 15 g/day in three divided doses — achievable with powder, essentially impossible with standard capsules [3,4].
• Take it on an empty stomach, at least two hours away from medication and mineral supplements [1,2].
• When buying, prioritise disclosed molecular weight, degree of esterification, galacturonic acid content and a batch certificate of analysis.

References

1. Cancer Research UK. Modified citrus pectin (MCP) — complementary and alternative therapies. https://www.cancerresearchuk.org/about-cancer/treatment/complementary-alternative-therapies/individual-therapies/modified-citrus-pectin-mcp
2. Memorial Sloan Kettering Cancer Center. Pectin — About Herbs, Botanicals & Other Products. https://www.mskcc.org/cancer-care/integrative-medicine/herbs/pectin
3. Guess BW, Scholz MC, Strum SB, et al. Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study. Prostate Cancer and Prostatic Diseases. 2003;6(4):301–304. https://www.nature.com/articles/4500679
4. Keizman D, Frenkel M, Peer A, et al. Modified citrus pectin treatment in non-metastatic biochemically relapsed prostate cancer: results of a prospective phase II study. Nutrients. 2021;13(12):4295. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706421/
5. Keizman D, Frenkel M, Peer A, et al. Modified citrus pectin treatment in non-metastatic biochemically relapsed prostate cancer: long-term results of a prospective phase II study. Nutrients. 2023;15(16):3533 — including the authors' stated limitations on the absence of a placebo arm and responder-enriched sampling. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459199/
6. Eliaz I, Hotchkiss AT, Fishman ML, Rode D. The effect of modified citrus pectin on urinary excretion of toxic elements. Phytotherapy Research. 2006;20(10):859–864. https://onlinelibrary.wiley.com/doi/abs/10.1002/ptr.1953
7. Zhao ZY, Liang L, Fan X, et al. The role of modified citrus pectin as an effective chelator of lead in children hospitalized with toxic lead levels. Alternative Therapies in Health and Medicine. 2008;14(4):34–38. https://pubmed.ncbi.nlm.nih.gov/18616067/
8. Kelly GS. Is modified citrus pectin an effective mobilizer of heavy metals in humans? Alternative Medicine Review. 2008;13(4):283. https://altmedrev.com/wp-content/uploads/2019/02/v13-4-283.pdf
9. Eliaz I, Raz A. Pleiotropic effects of modified citrus pectin. Nutrients. 2019;11(11):2619. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893732/
10. Kolatsi-Joannou M, Price KL, Winyard PJ, Long DA. Modified citrus pectin reduces galectin-3 expression and disease severity in experimental acute kidney injury. PLoS ONE. 2011;6(4):e18683. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072992/
11. Gehlken C, Suthahar N, Meijers WC, de Boer RA. Galectin-3 in heart failure: an update of the last 3 years. Heart Failure Clinics. 2018;14(1):75–92. https://pubmed.ncbi.nlm.nih.gov/29153203/
12. Imran TF, Shin HJ, Mathenge N, et al. Meta-analysis of the usefulness of plasma galectin-3 to predict the risk of mortality in patients with heart failure and in the general population. American Journal of Cardiology. 2017. https://pubmed.ncbi.nlm.nih.gov/28247849/
13. Brouns F, Theuwissen E, Adam A, et al. Cholesterol-lowering properties of different pectin types in mildly hyper-cholesterolemic men and women. European Journal of Clinical Nutrition. 2012;66(5):591–599. https://pubmed.ncbi.nlm.nih.gov/22190137/
14. EFSA Panel on Food Additives and Nutrient Sources. Re-evaluation of pectin (E 440i) and amidated pectin (E 440ii) as food additives. EFSA Journal. 2017;15(7):e04866. https://www.efsa.europa.eu/en/efsajournal/pub/4866
15. Weber AM, Pascale N, Gu F, et al. Nutrition and health effects of pectin: a systematic scoping review of human intervention studies. Nutrition Research Reviews. 2025;38(1):306–323. https://www.cambridge.org/core/journals/nutrition-research-reviews/article/nutrition-and-health-effects-of-pectin-a-systematic-scoping-review-of-human-intervention-studies/01BF0759F09A2BBC419F333B8B1D4FF9
16. Food Standards Agency. Food supplements — business guidance. https://www.food.gov.uk/business-guidance/food-supplements
17. GOV.UK. Food supplements guidance: how to consume food supplements safely. https://www.gov.uk/government/publications/food-supplements-guidance

All product photography in this article is owned by Welzo and served from the Welzo media library. Research positions correct at the time of publication.